<DOC>
	<DOCNO>NCT00577057</DOCNO>
	<brief_summary>The objective clinical study threefold : 1 . To compare benefit cancer control survival obtain add induction-concurrent chemotherapy radiation add concurrent-adjuvant chemotherapy radiation . 2 . To test whether replace fluorouracil Xeloda combine cisplatin ( PF PX , respectively ) chemotherapy plan maintain improve chemotherapy benefit reduce duration hospital stay . 3 . To see accelerated fractionation radiotherapy improve outcome patient compare conventional fractionation radiotherapy .</brief_summary>
	<brief_title>Benefit Changing Chemoradiotherapy Sequence Modifying Radiotherapy Schedule Advanced Nasopharyngeal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically proven nasopharyngeal carcinoma Nonkeratinizing undifferentiated type Stage IIIIVB ( AJCC/UICC 6th edition ) Essential stag investigation : CT MRI nasopharyngeal region Chest xray ( CT thorax ) Liver function test , alkaline phosphatase Liver bone scan alkaline phosphatase exceed institutional upper limit normal , clinically indicate . Liver scan SGOT exceed institutional upper limit normal Adequate marrow : WBC &gt; 4 platelet &gt; 100 Adequate renal function : creatinine clearance &gt; 60 ml/min . Satisfactory performance status : &gt; 2 ECOG System . WHO Type I squamous cell carcinoma adenocarcinoma Age &gt; 70 Treatment palliative intent ( include tumor extent mandate use AP oppose faciocervical field technique ) Prior malignancy except adequately treat basal cell squamous cell skin cancer , insitu cervical cancer , cancer patient diseasefree five year . Pregnancy lactation ( consider pregnancy test woman childbearing age emphasize effective contraception treatment period ) . History previous RT ( except nonmelanomatous skin cancer outside intend RT treatment volume ) . Prior chemotherapy surgery ( except diagnostic ) primary tumor node .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Nasopharyngeal Carcinoma</keyword>
	<keyword>Stage III - IVB</keyword>
</DOC>